CAS: 210101-16-9 - N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide

Formula: C₃₂H₂₆N₄O₂

InChI: InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37)

InChI key: InChIKey=IKENVDNFQMCRTR-UHFFFAOYSA-N

SMILES: O=C(NC1=CC=C(C=C1)C(=O)N2C=3C=CC=CC3C=4NC(=NC4CC2)C)C=5C=CC=CC5C=6C=CC=CC6

Synonyms:

• Conivaptan
• Conviaptan
• N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1′-Biphenyl]-2-carboxamide
• Zinc 12503187
• [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl]-
• [1,1′-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-

Conivaptan

CAS: 210101-16-9

Conivaptan is a drug that has been shown to be effective in the prevention and …

• Formula: C₃₂H₂₆N₄O₂
• Purity: Min. 95%
• Color and Shape: Powder
• Molecular weight: 498.58 g/mol